Otsuka To Buy Astex Pharma For Access To Cancer-Drug Pipeline
This article was originally published in PharmAsia News
Executive Summary
Otsuka Holdings plans to acquire Astex Pharmaceuticals for an undisclosed figure to give it access to the U.S.-based start-up's pipeline of cancer drugs.